Cigarette smoke extracts inhibit prostacyclin synthesis by the rat urinary bladder
Author(s) -
Jamie Y. Jeremy,
Dimitri P. Mikhailidis,
Paresh Dandona
Publication year - 1985
Publication title -
british journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.833
H-Index - 236
eISSN - 1532-1827
pISSN - 0007-0920
DOI - 10.1038/bjc.1985.129
Subject(s) - nicotine , cotinine , prostacyclin , carcinogen , metabolite , urinary bladder , urinary system , pharmacology , chemistry , bladder cancer , medicine , urothelium , cigarette smoke , cancer , biochemistry , environmental health
Since prostacyclin (PGI2) is known to have a cytoprotective effect on epithelia, and since cigarette smoking is associated with an increased risk of bladder cancer, we investigated the possibility that nicotine, cotinine (the principal metabolite of nicotine) and other components of cigarette smoke inhibit PGI2 secretion by the urinary bladder. Using the rat urinary bladder as a model, we found that cigarette smoke extracts, but not nicotine or cotinine, inhibit in vitro PGI2 synthesis. 2-Naphthylamine, a known bladder carcinogen, was also a potent inhibitor of PGI2 synthesis by the rat bladder. It is possible that cigarette smoke and 2-napthylamine exert their carcinogenic effect partly through the inhibition of PGI2 synthesis, resulting in diminished urothelial cytoprotection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom